| Subscribe To Our Free Newsletter |
Alembic Pharma Q2 Results: Firm posts Rs 137-crore net profit
Revenues grew 8% to Rs.1595 crore in Q2FY24 compared to Rs 1475 crore last year. The earnings before interest, tax, depreciation and amortization (EBITA) declined 6% YoY to Rs 218 crore. The EBITDA margins stood at 14% in Q2FY24.
